[HTML][HTML] The role of 3D exoscope systems in neurosurgery: an optical innovation
The development of the three-dimensional (3D) exoscope is a marvel of technological
innovation in modern surgical practice. While its predecessor, the operating microscope …
innovation in modern surgical practice. While its predecessor, the operating microscope …
Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations
SR Grobmyer, JD Reith, A Shahlaee… - Journal of surgical …, 2008 - Wiley Online Library
Abstract Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are rare tumors that often
occur in patients with neurofibromatosis 1. Surgical resection represents the mainstay of …
occur in patients with neurofibromatosis 1. Surgical resection represents the mainstay of …
Peripheral nervous system involvement in patients with cancer
JC Antoine, JP Camdessanché - The Lancet Neurology, 2007 - thelancet.com
Involvement of the peripheral nervous system (PNS) is common in patients with cancer and
any part, including motor neurons, sensory ganglia, nerve roots, plexuses, cranial and …
any part, including motor neurons, sensory ganglia, nerve roots, plexuses, cranial and …
Neoplasms Associated with Germline and Somatic NF1 Gene Mutations
S Patil, RS Chamberlain - The oncologist, 2012 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Describe phenotypic and clinical features associated with neurofibromatosis 1. Identify …
Describe phenotypic and clinical features associated with neurofibromatosis 1. Identify …
Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases
BW Scheithauer, S Erdogan, FJ Rodriguez… - The American journal …, 2009 - journals.lww.com
Malignant peripheral nerve sheath tumors (MPNSTs) arising from cranial nerves or their
branches are very uncommon. The literature consists mainly of isolated case reports and …
branches are very uncommon. The literature consists mainly of isolated case reports and …
Anti–vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors
HK Wong, J Lahdenranta, WS Kamoun, AW Chan… - Cancer research, 2010 - AACR
Patients with bilateral vestibular schwannomas associated with neurofibromatosis type 2
(NF2) experience significant morbidity such as complete hearing loss. We have recently …
(NF2) experience significant morbidity such as complete hearing loss. We have recently …
Management of benign retroperitoneal schwannomas: a single-center experience
DC Strauss, YA Qureshi, AJ Hayes… - The American Journal of …, 2011 - Elsevier
BACKGROUND: We describe the presentation, diagnostic pathway, and management of 28
patients with benign retroperitoneal schwannomas. METHODS: A prospectively kept soft …
patients with benign retroperitoneal schwannomas. METHODS: A prospectively kept soft …
Schwannomatosis: the overlooked neurofibromatosis?
NA Koontz, AL Wiens, A Agarwal… - American Journal of …, 2013 - Am Roentgen Ray Soc
OBJECTIVE. Schwannomas are typically benign tumors that occur sporadically, in
neurofibromatosis type 2 (NF2), or in an entity called “schwannomatosis.” Schwannomatosis …
neurofibromatosis type 2 (NF2), or in an entity called “schwannomatosis.” Schwannomatosis …
Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program
ES Amirian, JC Goodman, P New… - Journal of neuro …, 2014 - Springer
Malignant peripheral nerve sheath tumors (MPNSTs) are rare soft tissue sarcomas that arise
predominantly from Schwann cells. Despite the fact that MPNSTs have high local recurrence …
predominantly from Schwann cells. Despite the fact that MPNSTs have high local recurrence …
Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism
HK Wong, A Shimizu, ND Kirkpatrick, I Garkavtsev… - Neoplasia, 2012 - Elsevier
Abstract Neurofibromatosis type 2 (NF2) is an autosomal-dominant multiple neoplasia
syndrome that results from mutations in the NF2 tumor suppressor gene. Patients with NF2 …
syndrome that results from mutations in the NF2 tumor suppressor gene. Patients with NF2 …